Umeclidinium bromide/vilanterol

From Wikipedia, the free encyclopedia
Umeclidinium bromide/vilanterol
Combination of
Umeclidinium bromide Anticholinergic
Vilanterol Beta2-adrenergic agonist
Clinical data
Trade names Anoro Ellipta
AHFS/Drugs.com entry
Legal status ℞-only (US)
Routes Inhalation
Identifiers
ATC code R03AL03

Umeclidinium bromide/vilanterol (trade name Anoro Ellipta) is a combination drug approved for the treatment of chronic obstructive pulmonary disease (COPD).[1][2] It is applied as an inhalation.

References

  1. ↑ Feldman, GJ; Edin, A (2013). "The combination of umeclidinium bromide and vilanterol in the management of chronic obstructive pulmonary disease: Current evidence and future prospects". Therapeutic advances in respiratory disease 7 (6): 311–9. doi:10.1177/1753465813499789. PMID 24004659. 
  2. ↑ "FDA Approves Umeclidinium and Vilanterol Combo for COPD". Medscape. December 18, 2013. 
Drugs for obstructive airway diseases: asthma/COPD (R03)
Adrenergics, inhalants
Short acting β2-agonists
  • Bitolterol
  • Carbuterol
  • Fenoterol
  • Pirbuterol
  • Procaterol
  • Reproterol
  • Rimiterol
  • Salbutamol#/Levosalbutamol
  • Terbutaline
  • Tulobuterol
Long acting β2-agonists (LABA)
  • Arformoterol
  • Bambuterol
  • Clenbuterol
  • Formoterol
  • Salmeterol
  • Ultra LABA: Indacaterol, Olodaterol, Vilanterol
other
  • Epinephrine#
  • Hexoprenaline
  • Isoprenaline (Isoproterenol)
  • Orciprenaline (Metaproterenol)
Glucocorticoids
  • Beclometasone#
  • Betamethasone
  • Budesonide
  • Ciclesonide
  • Flunisolide
  • Fluticasone
  • Mometasone
  • Triamcinolone
Anticholinergics/
muscarinic antagonist
  • Aclidinium bromide
  • Glycopyrronium bromide
  • Ipratropium bromide#
  • Oxitropium bromide
  • Tiotropium bromide
  • Umeclidinium
Mast cell stabilizers
  • Cromoglicate
  • Nedocromil
Xanthines
  • Acefylline
  • Ambuphylline
  • Bamifylline
  • Doxofylline
  • Enprofylline
  • Etamiphylline
  • Proxyphylline
  • Theobromine
  • Theophylline/Aminophylline/Choline theophyllinate
Eicosanoid inhibition
Leukotriene antagonists
  • Montelukast
  • Pranlukast
  • Zafirlukast
Lipoxygenase inhibitor
  • Zileuton
Thromboxane receptor antagonists
  • Ramatroban
  • Seratrodast
Non-xanthine PDE4 inhibitors
  • Ibudilast
  • Roflumilast
Others/unknown
  • Amlexanox
  • Eprozinol
  • Fenspiride
  • Omalizumab
Combination products
  • Budesonide/formoterol
  • Fluticasone/salmeterol
  • Ipratropium bromide/salbutamol
  • Mometasone/formoterol
  • Beclometasone/formoterol
  • Fluticasone/vilanterol
  • Umeclidinium bromide/vilanterol
  • #WHO-EM
  • ‡Withdrawn from market
  • Clinical trials:
    • †Phase III
    • §Never to phase III

M: RES

anat (n, x, l, c)/phys/devp

noco (c, p)/cong/tumr, sysi/epon, injr

proc, drug (R1/2/3/5/6/7)


This article is issued from Wikipedia. The text is available under the Creative Commons Attribution/Share Alike; additional terms may apply for the media files.